VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′

Issam Hmila, Ben Abderrazek Ben Abdallah R, Dirk Saerens, Zakaria Benlasfar, Katja Conrath, Mohamed El Ayeb, Serge Muyldermans, Balkiss Bouhaouala-Zahar

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Many efforts aim at solving the serious problems encountered with immunotherapy against scorpion envenoming. The most attractive approach consists in generating single-chain antibody fragments (scFv) as their pharmaco-kinetic properties should match closely those of the scorpion toxins. Although high affinity scFv reagents have been generated in the past, their production level, stability, and toxin neutralizing capacity remain disappointingly poor. In the current study, we identified one Nanobody (Nb), a single-domain antigen-binding fragment of a dromedary Heavy-chain antibody (HCAb) that recognizes specifically the Androctonus australis hector AahI′ toxin. This Nb has excellent production, stability and solubility characteristics. With this Nb we further manufactured a tandem linked bivalent construct and assembled a HCAb with improved antigen binding due to avidity effects. All these constructs were shown in mouse models to possess a scorpion toxin neutralization capacity that exceeds by far all previous attempts with scFv-based materials, even when used at lower doses. It is therefore clear that in the near future Nanobodies will be at the core of novel serotherapeutics as they combine multiple benefits over other reagents to treat scorpion envenomed patients.

Original languageEnglish
Pages (from-to)3847-3856
Number of pages10
JournalMolecular Immunology
Volume45
Issue number14
DOIs
Publication statusPublished - 1 Aug 2008
Externally publishedYes

Fingerprint

Single-Domain Antibodies
Scorpions
Antibodies
Antigens
Camelus
Single-Chain Antibodies
Immunoglobulin Fragments
Immunotherapy
Solubility

Keywords

  • Dromedary
  • Na channel specific toxin
  • Nanobody
  • Phage display
  • Recombinant antibody
  • Scorpion venom
  • Serotherapy
  • Toxin

ASJC Scopus subject areas

  • Immunology
  • Molecular Biology

Cite this

Hmila, I., Abdallah R, B. A. B., Saerens, D., Benlasfar, Z., Conrath, K., Ayeb, M. E., ... Bouhaouala-Zahar, B. (2008). VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′. Molecular Immunology, 45(14), 3847-3856. https://doi.org/10.1016/j.molimm.2008.04.011

VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′. / Hmila, Issam; Abdallah R, Ben Abderrazek Ben; Saerens, Dirk; Benlasfar, Zakaria; Conrath, Katja; Ayeb, Mohamed El; Muyldermans, Serge; Bouhaouala-Zahar, Balkiss.

In: Molecular Immunology, Vol. 45, No. 14, 01.08.2008, p. 3847-3856.

Research output: Contribution to journalArticle

Hmila, I, Abdallah R, BAB, Saerens, D, Benlasfar, Z, Conrath, K, Ayeb, ME, Muyldermans, S & Bouhaouala-Zahar, B 2008, 'VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′', Molecular Immunology, vol. 45, no. 14, pp. 3847-3856. https://doi.org/10.1016/j.molimm.2008.04.011
Hmila, Issam ; Abdallah R, Ben Abderrazek Ben ; Saerens, Dirk ; Benlasfar, Zakaria ; Conrath, Katja ; Ayeb, Mohamed El ; Muyldermans, Serge ; Bouhaouala-Zahar, Balkiss. / VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′. In: Molecular Immunology. 2008 ; Vol. 45, No. 14. pp. 3847-3856.
@article{4c48bab4226c413984fd89e2c1c12d66,
title = "VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′",
abstract = "Many efforts aim at solving the serious problems encountered with immunotherapy against scorpion envenoming. The most attractive approach consists in generating single-chain antibody fragments (scFv) as their pharmaco-kinetic properties should match closely those of the scorpion toxins. Although high affinity scFv reagents have been generated in the past, their production level, stability, and toxin neutralizing capacity remain disappointingly poor. In the current study, we identified one Nanobody (Nb), a single-domain antigen-binding fragment of a dromedary Heavy-chain antibody (HCAb) that recognizes specifically the Androctonus australis hector AahI′ toxin. This Nb has excellent production, stability and solubility characteristics. With this Nb we further manufactured a tandem linked bivalent construct and assembled a HCAb with improved antigen binding due to avidity effects. All these constructs were shown in mouse models to possess a scorpion toxin neutralization capacity that exceeds by far all previous attempts with scFv-based materials, even when used at lower doses. It is therefore clear that in the near future Nanobodies will be at the core of novel serotherapeutics as they combine multiple benefits over other reagents to treat scorpion envenomed patients.",
keywords = "Dromedary, Na channel specific toxin, Nanobody, Phage display, Recombinant antibody, Scorpion venom, Serotherapy, Toxin",
author = "Issam Hmila and {Abdallah R}, {Ben Abderrazek Ben} and Dirk Saerens and Zakaria Benlasfar and Katja Conrath and Ayeb, {Mohamed El} and Serge Muyldermans and Balkiss Bouhaouala-Zahar",
year = "2008",
month = "8",
day = "1",
doi = "10.1016/j.molimm.2008.04.011",
language = "English",
volume = "45",
pages = "3847--3856",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "14",

}

TY - JOUR

T1 - VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′

AU - Hmila, Issam

AU - Abdallah R, Ben Abderrazek Ben

AU - Saerens, Dirk

AU - Benlasfar, Zakaria

AU - Conrath, Katja

AU - Ayeb, Mohamed El

AU - Muyldermans, Serge

AU - Bouhaouala-Zahar, Balkiss

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Many efforts aim at solving the serious problems encountered with immunotherapy against scorpion envenoming. The most attractive approach consists in generating single-chain antibody fragments (scFv) as their pharmaco-kinetic properties should match closely those of the scorpion toxins. Although high affinity scFv reagents have been generated in the past, their production level, stability, and toxin neutralizing capacity remain disappointingly poor. In the current study, we identified one Nanobody (Nb), a single-domain antigen-binding fragment of a dromedary Heavy-chain antibody (HCAb) that recognizes specifically the Androctonus australis hector AahI′ toxin. This Nb has excellent production, stability and solubility characteristics. With this Nb we further manufactured a tandem linked bivalent construct and assembled a HCAb with improved antigen binding due to avidity effects. All these constructs were shown in mouse models to possess a scorpion toxin neutralization capacity that exceeds by far all previous attempts with scFv-based materials, even when used at lower doses. It is therefore clear that in the near future Nanobodies will be at the core of novel serotherapeutics as they combine multiple benefits over other reagents to treat scorpion envenomed patients.

AB - Many efforts aim at solving the serious problems encountered with immunotherapy against scorpion envenoming. The most attractive approach consists in generating single-chain antibody fragments (scFv) as their pharmaco-kinetic properties should match closely those of the scorpion toxins. Although high affinity scFv reagents have been generated in the past, their production level, stability, and toxin neutralizing capacity remain disappointingly poor. In the current study, we identified one Nanobody (Nb), a single-domain antigen-binding fragment of a dromedary Heavy-chain antibody (HCAb) that recognizes specifically the Androctonus australis hector AahI′ toxin. This Nb has excellent production, stability and solubility characteristics. With this Nb we further manufactured a tandem linked bivalent construct and assembled a HCAb with improved antigen binding due to avidity effects. All these constructs were shown in mouse models to possess a scorpion toxin neutralization capacity that exceeds by far all previous attempts with scFv-based materials, even when used at lower doses. It is therefore clear that in the near future Nanobodies will be at the core of novel serotherapeutics as they combine multiple benefits over other reagents to treat scorpion envenomed patients.

KW - Dromedary

KW - Na channel specific toxin

KW - Nanobody

KW - Phage display

KW - Recombinant antibody

KW - Scorpion venom

KW - Serotherapy

KW - Toxin

UR - http://www.scopus.com/inward/record.url?scp=48049096810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48049096810&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2008.04.011

DO - 10.1016/j.molimm.2008.04.011

M3 - Article

C2 - 18614235

AN - SCOPUS:48049096810

VL - 45

SP - 3847

EP - 3856

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 14

ER -